Skip to main content
Log in

Effect of Strontium Ranelate on Hydrogen Peroxide-Induced Apoptosis of CRL-11372 Cells

  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

In vitro and in vivo studies have proven strontium to be an osteoinductive trace element. The effect of strontium ranelate (SR) on H2O2-induced apoptosis of CRL-11372 cells and optimization of its anti-apoptotic dose were the aims of this study. After 1 h of pretreatment with SR 1 μM, 50 μM, 100 μM, 500 μM, and 1,000 μM concentrations, CRL-11372 osteoblasts were exposed to 100 μM H2O2 for periods of 6–12 h. The same experiments were repeated without H2O2. The apoptotic index and viability of cells were assessed quantitatively with a fluorescent dye and qualitatively with agarose gel electrophoresis. Concentrations of 1–100 μM of SR with a 6-h treatment and only 1 μM concentration with a 12-h treatment inhibited the apoptotic effect of H2O2 on cultured osteoblasts significantly (P < 0.05). SR was shown to inhibit H2O2-induced apoptosis of CRL-11372 cells in a dose-dependent manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Barbara A, Delannoy P, Denis BG, Marie PJ (2004) Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 53:532–537

    Article  PubMed  CAS  Google Scholar 

  • Baron R, Tsouderos Y (2002) In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450:11–17

    Article  PubMed  CAS  Google Scholar 

  • Brown EM (2003) Is the calcium receptor a molecular target for the actions of strontium on bone. Osteoporosis Int 14(Suppl. 3):S25–S34

    CAS  Google Scholar 

  • Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517–523

    Article  PubMed  CAS  Google Scholar 

  • Chua CC, Chua BH, Chen Z, Landy C, Hamdy RC (2003) Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1642:79–85

    Article  PubMed  CAS  Google Scholar 

  • Delannoy P, Bazot D, Marie PJ (2002) Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51:906–911

    Article  PubMed  CAS  Google Scholar 

  • Gong J, Traganos F, Darzynkiewicz Z (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314–319

    Article  PubMed  CAS  Google Scholar 

  • Grynpas MD, Marie PJ (1990) Effects of low doses of strontium on bone quality and bone quantity in rats. Bone 11:313–319

    Article  PubMed  CAS  Google Scholar 

  • Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995). Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178–186

    PubMed  CAS  Google Scholar 

  • Hott M, Deloffre P, Tsouderos Y, Marie PJ (2003) S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33:115–123

    Article  PubMed  CAS  Google Scholar 

  • Hurtel-Lemaire AS, Mentaverri R, Wattel A, Kamel S, Brazier M (2005) Proteinkinases C are involved in strontium ranelate-induced osteoclast apoptosis. Bone 36(Suppl. 2): S403

    Google Scholar 

  • Kovacić N, Lukić IK, Grcević D, Katavić V, Croucher P, Marusić A (2007) The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis. J Immunol 178:3379–3389

    PubMed  Google Scholar 

  • Liu AL, Zhang ZM, Zhu BF, Liao ZH, Liu Z (2004) Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell Biol Int 28:905–911

    Article  PubMed  CAS  Google Scholar 

  • Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615

    Article  PubMed  CAS  Google Scholar 

  • Marie PJ, Ammann P, Boivin G, Rey C (2001) Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69:121–129

    Article  PubMed  CAS  Google Scholar 

  • Mentaverri R, Hurtel-Lemaire AS, Wattel A, Kamel S, Brown EM, Brazier M (2005) Calcium-sensing receptor mediates strontium ranelate-induced osteoclast apoptosis. Bone 36(Suppl. 2):S403

    Google Scholar 

  • Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C et al (2002) Strontium ranelate: dose-dependent effects on established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial. J Clin Endocrinol 87:2060–2066

    Article  CAS  Google Scholar 

  • Meunier PJ, Roux C, Seeman E, Ortoloni S, Baduriski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausel osteoporosis. N Eng J Med 350:459–468

    Article  CAS  Google Scholar 

  • Park BY, Yoo CI, Kim HT, Kwon CH, Kim YK (2005) Role of mitogen-activated protein kinases in hydrogen peroxide-induced cell death in osteoblastic cells. Toxicology 215:115–125

    Article  PubMed  CAS  Google Scholar 

  • Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW (2006) Effect of strontium ions, on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffold. Biomaterials 27:1277–1286

    Article  PubMed  CAS  Google Scholar 

  • Reginster JY (2002) Strontium ranelate in osteoporosis. Curr Pharm Des 8:1907–1916

    Article  PubMed  CAS  Google Scholar 

  • Reginster JY, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C (2002) Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two year, double masked, dose ranging, placebo-controlled PREVOS trial. Osteoporos Int 13:925–931

    Article  PubMed  CAS  Google Scholar 

  • Swanson SM, Ijaz A, Fahning ML (1987) The use of acridine orange and ethidium bromide to determine the viability of pre-implantation mouse embryos cultured in vitro. Br Vet J 143:306–311

    PubMed  CAS  Google Scholar 

  • Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18:1082–1087

    Article  PubMed  CAS  Google Scholar 

  • Tsuji M, Ikeda H, Ishizu A, Miyatake Y, Hayase H, Yoshiki T (2006) Altered expression of apoptosis-related genes in osteocytes exposed to high-dose steroid hormones and hypoxic stress. Pathobiology. 73:304–309

    Article  PubMed  CAS  Google Scholar 

  • Verberckmoes SC, De Broe ME, D’Haese PC (2003) Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int 64:534–543

    Article  PubMed  CAS  Google Scholar 

  • Weinstein RS, Manolagas SC (2000) Apoptosis and osteoporosis. Am J Med 108:153–164

    Article  PubMed  CAS  Google Scholar 

  • Xie H, Tang SY, Li H, Luo XH, Yuan LQ, Wang D, Liao EY (2007) l-Carnitine protects against apoptosis of murine MC3T3-E1 osteoblastic cells. Amino Acids. 2007 Oct 2; [Epub ahead of print]

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Ali Ergun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senkoylu, A., Yilmaz, A., Ergun, M.A. et al. Effect of Strontium Ranelate on Hydrogen Peroxide-Induced Apoptosis of CRL-11372 Cells. Biochem Genet 46, 197–205 (2008). https://doi.org/10.1007/s10528-008-9142-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-008-9142-1

Keywords

Navigation